Literature DB >> 3335641

Modulation of conduction and refractoriness in atrioventricular junctional reentrant circuit. Effect on reentry initiated by atrial extrastimulus.

R Mahmud1, S T Denker, P J Tchou, M Jazayeri, M Akhtar.   

Abstract

The importance of activation sequence of an atrioventricular junctional reentrant (AVJRe) circuit, before delivery of an extrastimulus, has received little attention in studies concerned with clinical tachycardias. In this study a change in activation sequence was accomplished using bidirectional activation (V-A sequential pacing) during the basic drive (V1A1-V1A1). It was noted that, compared with an atrial extrastimulus (A2) after an atrial drive (A1-A1), earlier activation (by V1 impulse of the V1A1-V1A1 drive) consistently improved conduction, or decreased refractoriness, or both, in the anterograde as well as the retrograde pathway of the AVJRe circuit. In all patients, five with AV nodal reentry and six with Wolff-Parkinson-White syndrome, reentrant tachycardia could be prevented during V-A sequential pacing. In four of eleven patients, reentry was prevented despite achieving the so-called critical atrioventricular nodal delays that had previously caused reentry during control study. This finding suggested that conduction delay necessary for reentry was related to the site of block, which in turn was affected by V-A sequential pacing. We concluded that changing the activation sequence during basic drive modulates conduction and refractoriness in AVJRe circuits, and allows the study of a wide range of electrophysical factors that prevent or permit reentry.

Entities:  

Mesh:

Year:  1988        PMID: 3335641      PMCID: PMC442470          DOI: 10.1172/JCI113307

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  [Cardiac stimulation technics in the treatment of tachycardia].

Authors:  P Coumel; R Slama; Y Bouvrain
Journal:  Sem Hop       Date:  1972-11-08

2.  The effects of cycle length on cardiac refractory periods in man.

Authors:  P Denes; D Wu; R Dhingra; R J Pietras; K M Rosen
Journal:  Circulation       Date:  1974-01       Impact factor: 29.690

3.  Demonstration of dual A-V nodal pathways in patients with paroxysmal supraventricular tachycardia.

Authors:  P Denes; D Wu; R C Dhingra; R Chuquimia; K M Rosen
Journal:  Circulation       Date:  1973-09       Impact factor: 29.690

4.  Circus movement within the AV node as a basis for supraventricular tachycardia as shown by multiple microelectrode recording in the isolated rabbit heart.

Authors:  M J Janse; F J van Capelle; G E Freud; D Durrer
Journal:  Circ Res       Date:  1971-04       Impact factor: 17.367

5.  An in vitro model of paroxysmal supraventricular tachycardia.

Authors:  A L Wit; B N Goldreyer; A N Damato
Journal:  Circulation       Date:  1971-06       Impact factor: 29.690

6.  The essential role of atrioventricular conduction delay in the initiation of paroxysmal supraventricular tachycardia.

Authors:  B N Goldreyer; A N Damato
Journal:  Circulation       Date:  1971-05       Impact factor: 29.690

7.  Functional characteristics of retrograde conduction in a pacing model of "endless loop tachycardia".

Authors:  R Mahmud; S Denker; M Lehmann; C Gilbert; M Akhtar
Journal:  J Am Coll Cardiol       Date:  1984-06       Impact factor: 24.094

8.  Slow conduction and reentry in the ventricular conducting system. II. Single and sustained circus movement in networks of canine and bovine Purkinje fibers.

Authors:  A L Wit; P F Cranefield; B F Hoffman
Journal:  Circ Res       Date:  1972-01       Impact factor: 17.367

9.  The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome.

Authors:  D Durrer; L Schoo; R M Schuilenburg; H J Wellens
Journal:  Circulation       Date:  1967-11       Impact factor: 29.690

10.  The mechanism of supraventricular tachycardia.

Authors:  J T Bigger; B N Goldreyer
Journal:  Circulation       Date:  1970-10       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.